PMID: 11898502Mar 20, 2002Paper

Progress in the pathogenesis of amyotrophic lateral sclerosis

Current Neurology and Neuroscience Reports
C E ShawN Leigh

Abstract

This decade has seen the discovery of one cause for amyotrophic lateral sclerosis (ALS)--mutations in the copper/zinc superoxide dismutase (SOD1) gene. Mutant SOD1 has provided an invaluable tool for transgenic and cellular experiments designed to elicit the biochemical pathways that are disturbed in ALS. We highlight recent advances in ALS research, including diagnostic issues, new loci for ALS genes, and progress in understanding the toxicity of mutant SOD1. The evidence for persistant viral infection, glutamate-mediated excitotoxicity, oxidative stress, altered neurofilament and peripherin expression, disrupted axonal transport, neurotrophin deficiency, and mitochondrial dysfunction are critically reviewed. As yet, no consensus has been achieved on the pathways that lead to selective neuronal death, and the underlying causes are still unknown in the vast majority of patients. Further clues about genetic susceptibility and environmental triggers are urgently needed so that more effective treatments for ALS can be developed, with the ultimate goal being prevention.

Associated Clinical Trials

References

May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Jul 1, 1990·Annals of Neurology·J D RothsteinJ T Coyle
Oct 1, 1995·Annals of Neurology·P J ShawD Mantle
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
Aug 12, 1993·Nature·J S BeckmanW H Koppenol
Nov 1, 1996·The Journal of Cell Biology·J R MarszalekD W Cleveland
May 1, 1997·Journal of Neuropathology and Experimental Neurology·H D DurhamD A Figlewicz
Mar 21, 1998·Neuroscience Letters·T MeyerA C Ludolph
Mar 20, 1998·Annals of Neurology·C E ShawP N Leigh
Jun 20, 1998·Neuropathology and Applied Neurobiology·P G InceP J Shaw
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Couillard-DesprésJ P Julien
Sep 23, 1998·Experimental Neurology·R H SwerdlowW D Parker
Dec 16, 1998·Journal of the Neurological Sciences·J B KurekE Byrne
Feb 5, 1999·Human Molecular Genetics·A Al-ChalabiP N Leigh
Jun 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·C M EllisP N Leigh
Aug 4, 1999·Brain : a Journal of Neurology·B A RabinD R Cornblath

❮ Previous
Next ❯

Citations

Nov 8, 2008·Acta Neuropathologica·Takashi KasaiMasanori Nakagawa
Apr 15, 2004·Medical Hypotheses·Roger Pamphlett
Jan 28, 2003·Drug Discovery Today·Peter M Mathisen
Jan 11, 2013·Cell Death & Disease·A VaarmannA Y Abramov
Jun 14, 2012·European Journal of Human Genetics : EJHG·Bradley N SmithChristopher E Shaw
Aug 16, 2008·The Journal of Biological Chemistry·Jayarama Krishnan BoseC-K James Shen
Mar 1, 2008·Science·Jemeen SreedharanChristopher E Shaw
Jul 10, 2003·Lancet Neurology·Andrew H Crosby
Oct 17, 2006·Expert Opinion on Investigational Drugs·John P Crow
Oct 27, 2004·Expert Opinion on Drug Safety·Gilbert Bensimon, Adam Doble
Sep 13, 2014·Neurological Research·MuDan CaiEun Jin Yang
Aug 16, 2012·Neurobiology of Aging·Lauren JohnsonChristopher E Shaw
Nov 20, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Nadia A SutedjaLeonard H van den Berg
Jun 21, 2006·Biochimica Et Biophysica Acta·Diether Lambrechts, Peter Carmeliet
Jul 4, 2003·American Journal of Human Genetics·Deborah M RuddyChristopher E Shaw
May 29, 2016·Progress in Neurobiology·Mónica ZufiríaAdolfo López de Munain
Oct 30, 2016·RNA Biology·Francesca SvetoniMaria Paola Paronetto
Sep 2, 2009·Arquivos de neuro-psiquiatria·Acary Souza Bulle Oliveira, Roberto Dias Batista Pereira
Jun 19, 2004·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·P Nigel LeighLeonard Van Den Berg
Aug 16, 2006·Neuro-degenerative Diseases·Eva Ekestern
Jan 24, 2019·Soft Matter·Hanieh Falahati, Amir Haji-Akbari
Feb 5, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jolyn FernandesDean P Jones
Feb 24, 2006·Brain : a Journal of Neurology·Caroline VanceChristopher E Shaw
Jul 17, 2012·Metallomics : Integrated Biometal Science·Megan W Bourassa, Lisa M Miller
Jan 12, 2020·Glia·Martina de MajoErik M Ullian
Mar 11, 2016·The Journal of Toxicological Sciences·Yui NakajimaYo Shinoda
Oct 5, 2006·Experimental Biology and Medicine·Per M RoosMonica Nordberg
Jul 14, 2018·Frontiers in Molecular Neuroscience·Michelle Lindström, Beidong Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.